Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01219062
Other study ID # Si391/2010
Secondary ID
Status Terminated
Phase Phase 4
First received September 15, 2010
Last updated October 3, 2016
Start date September 2010
Est. completion date April 2011

Study information

Verified date October 2016
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

Falls are a common problem in elderly people which they have to receive the operation. Hemiarthroplasty is one of the common orthopedics operations. The prompt operation and good pain control will provide the good recovery and outcome. The investigators compare the efficacy of postoperative pain control between Intrathecal morphine 0.1 milligrams (mg.) with the local infiltration of 0.25% Bupivacaine for 20 milliliters (ml.) in patients received hip hemiarthroplasty under spinal anesthesia.


Description:

Study process All the patients who assigned the hip hemiarthroplasty without any exclusion criteria will be enrolled in the study and be divided into 3 groups randomly

1. control group : the patients will be received spinal anesthesia with 0.5% Isobaric Bupivacaine and postoperative pain control by intravenous (IV) Patient - control Analgesia (PCA)

2. Morphine group : the patients will be received 0.1 mg. of Morphine added in Isobaric Bupivacaine for spinal anesthesia and postoperative pain control by IV PCA

3. Local group : the patients will be received spinal anesthesia and periarticular tissue infiltration with 0.25% Bupivacaine and postoperative pain control by IV PCA

Data collection

1. Demographic data : age, sex, Body Weight, Body Mass Index (BMI), ...

2. Pain score every 3 hours postoperatively in the first 6 hours and at the 12th hours by visual analogue scoring system

3. Patient global assessment and patient satisfactory visual analogue scoring system at 24th and 48th hour

4. the amount of morphine during 24 and 48 hours postoperative and the time of first dose they received


Recruitment information / eligibility

Status Terminated
Enrollment 10
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- age between 18-90 years

- Co-operative, able to use PCA

- ASA classification 1-3

- no contraindication for Spinal Anesthesia

- patient acceptance for spinal anesthesia

- body weight > 30 kg.

- BMI between 20-35

- no history of drug allergy, e.g. Local Anesthetics, Paracetamol, etc.

Exclusion Criteria:

- age > 90 years

- previous Hemiarthroplasty (the same site)

- pathological fracture such as severe infection, bone cancer

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Drug:
morphine
periarticular infiltration with 0.25% Bupivacaine for 20 ml.
Other:
control
the patients will be received spinal anesthesia with 0.5% Isobaric Bupivacaine and postoperative pain control by intravenous (IV) Patient - control Analgesia (PCA)
Drug:
Bupivacaine
the patients will be received spinal anesthesia and periarticular tissue infiltration with 0.25% Bupivacaine and postoperative pain control by IV PCA

Locations

Country Name City State
Thailand Faculty of Medicine Siriraj Hospital Bangkok
Thailand Thitima Chinachot Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Amount of Morphine consumption after Hemiarthroplasty 24 hours Yes
Secondary Efficacy of pain control Efficacy of pain control measured by
the amount of morphine which the patient needed to keep pain score 2-3
patient global assessment
patient satisfaction assessed by visual analogue scale
incidence of adverse effect such as pruritus, nausea and vomiting,...
48 hours Yes
See also
  Status Clinical Trial Phase
Completed NCT02422355 - A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures
Withdrawn NCT02202122 - Interest of the OSA (Obstructive Sleep Apnea) Predictive Scores in the Prognosis of Postoperative Mortality of Femoral Neck Fractures N/A
Active, not recruiting NCT02362971 - External Validity of a Randomized Trial in Patients With a Femoral Neck Fracture N/A
Completed NCT02591342 - Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture N/A
Recruiting NCT05171140 - Influence of the Spatial Distribution of Hollow Screws on the Blood Supply and Prognosis of Femoral Neck Fractures N/A
Completed NCT02433548 - Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture Phase 4
Active, not recruiting NCT03357445 - AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study N/A
Recruiting NCT03550079 - Fixation for the Treatment of Femoral Neck Fractures N/A
Completed NCT04879472 - Early Functional Outcome of Operative Treatment of Displaced Femoral Neck Fractures in Two Kenyan Orthopaedic Centres
Completed NCT00913679 - A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty N/A
Recruiting NCT02877472 - Porous Tantalum Rods Improve the Hip Joint Function of Patients With Avascular Necrosis of the Femoral Head N/A
Recruiting NCT01112436 - The Effect of Periarticular Multi-Drug Regimen on Pain After Partial Hip Replacement Phase 4
Completed NCT01052974 - Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol Phase 4
Terminated NCT02030431 - Dynaloc for Treatment of Femoral Neck Fractures N/A
Completed NCT01114646 - Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty N/A
Completed NCT02512094 - Validity and Reliability of Thai Version of Barthel Index for Hip Fracture Patients N/A
Recruiting NCT02148848 - Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty Phase 4
Completed NCT01644227 - Dual Mobility Cup in Total Hip Arthroplasty Preventing Dislocation in Patients at Risk N/A
Active, not recruiting NCT02901938 - Feasibility of Implantation of Cemented Femoral Stem for Osteoporotic Femoral Neck Fracture in Elderly Patients N/A
Completed NCT02771639 - Early Periprosthetic Joint Infection and Outcome Debridement, Antibiotics and Implant Retention N/A